Ansamycin formulations and methods of use thereof
US7947670B2 · kind B2 · utility
2Cited by
13References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 11, 2007 |
| Grant date | May 24, 2011 |
| Priority date | — |
| Expiry date | Mar 29, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D225/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein, inter alia, are solid forms of geldanamycin analogs, pharmaceutical compositions comprising a geldanamycin analog and a crystallization inhibitor, methods of making and using such compositions. Additionally, provided are methods for the treatment of cancer, a neoplastic disease state and/or a hyperproliferative disorder, and methods of inhibiting Heat Shock Protein 90 (“Hsp90”).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.